AGP Picks
View all

STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

Press releases published on June 3, 2026

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)
GigaCloud Technology Inc Named to TIME’s ‘World’s Growth Leaders 2026’ List
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for May 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics
 Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för maj 2026 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
79% of Enterprises Are Confident They Can Scale AI Without Breaking Governance. Only 29% Can Even Find the Data.
FactSet Schedules Third Quarter 2026 Earnings Call
SweetWater Brewing Unveils Atlanta-Wide Soccer Celebration as Global Fans Descend on the City This Summer
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
Joveo Introduces AI Talent Campaigns to Help Recruiters Launch Multi-Touch Outreach in Minutes
Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms
Dark Horse Consulting Group and Altruist Biologics Announce Memorandum of Understanding to Advance Biologics Manufacturing and Development in China
Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Share this page:

Sign up for:

STEM Minnesota

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.